University of Pittsburgh Announces 9 U.S. Patents Issued to Pitt Innovators in September 2026
Pitt innovators were issued nine U.S. patents in September 2026. Featured patent: 12,746,528: Hydrogel... Read more
Pitt innovators were issued nine U.S. patents in September 2026. Featured patent: 12,746,528: Hydrogel... Read more
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
Renerva’s main focus is to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures. The company is committed to developing the next generation of surgical solutions to improve peripheral nerve repair, accelerate healing following a nerve injury, and improve nerve function following injury and repair.
University of Pittsburgh
Powered by AI. Please verify important information.